Trial Profile
A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Telmisartan and S-Amlodipine(CKD-828) Versus Telmisartan Monotherapy in Hypertensive Patients Inadequately Controlled by Telmisartan Monotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Telmisartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms CKD-828-TEL-Phase 3
- Sponsors Chong Kun Dang
- 06 Oct 2016 Primary endpoint has been met. (Mean Sitting Diastolic Blood Pressure (MSDBP))
- 06 Oct 2016 Results published in the Clinical Therapeutics
- 29 Sep 2016 Results presented at the 26th Scientific Meeting of the International Society of Hypertension